The 10-second takeaway
For the quarter ended Dec. 31 (Q4), WebMD Health beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue dropped. Non-GAAP earnings per share contracted significantly. GAAP earnings per share contracted to a loss.
Margins dropped across the board.
WebMD Health logged revenue of $132.7 million. The five analysts polled by S&P Capital IQ expected a top line of $124.5 million on the same basis. GAAP reported sales were 12% lower than the prior-year quarter's $150.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.03. The three earnings estimates compiled by S&P Capital IQ predicted -$0.07 per share. Non-GAAP EPS of $0.03 for Q4 were 88% lower than the prior-year quarter's $0.24 per share. GAAP EPS were -$0.12 for Q4 against $0.28 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 58.3%, 650 basis points worse than the prior-year quarter. Operating margin was 9.6%, much worse than the prior-year quarter. Net margin was -4.6%, much worse than the prior-year quarter.
Next quarter's average estimate for revenue is $105.8 million. On the bottom line, the average EPS estimate is -$0.05.
Next year's average estimate for revenue is $445.7 million. The average EPS estimate is -$0.29.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 111 members out of 166 rating the stock outperform, and 55 members rating it underperform. Among 49 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 35 give WebMD Health a green thumbs-up, and 14 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on WebMD Health is hold, with an average price target of $14.00.
Internet software and services are being consumed in radically different ways, on new and increasingly mobile devices. Is WebMD Health on the right side of the revolution? Check out the changing landscape and meet the company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add WebMD Health to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.